Precision Biosciences (DTIL) Cash from Investing Activities Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -122.45% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 63.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.69% |
| Dec 31, 2025 | -235.05% |
| Sep 30, 2025 | 126.56% |
| Jun 30, 2025 | 57.14% |
| Mar 31, 2025 | -1,107.69% |
| Dec 31, 2024 | -330.95% |
| Sep 30, 2024 | -100.85% |
| Jun 30, 2024 | 97.35% |
| Mar 31, 2024 | 96.39% |
| Dec 31, 2023 | 106.65% |
| Sep 30, 2023 | 793.94% |
| Jun 30, 2023 | -35.56% |
| Mar 31, 2023 | 11.86% |
| Dec 31, 2022 | 58.01% |
| Sep 30, 2022 | 26.50% |
| Jun 30, 2022 | 53.91% |
| Mar 31, 2022 | 27.29% |
| Dec 31, 2021 | -37.32% |
| Sep 30, 2021 | -41.64% |
| Jun 30, 2021 | 5.32% |
| Mar 31, 2021 | -1.99% |
| Dec 31, 2020 | 80.18% |
| Sep 30, 2020 | 82.31% |
| Jun 30, 2020 | 78.06% |
| Mar 31, 2020 | 78.30% |
| Dec 31, 2019 | 43.99% |
| Sep 30, 2019 | -46.30% |
| Jun 30, 2019 | -621.37% |
| Mar 31, 2019 | -721.00% |